Ginkgo Bioworks Holdings, Inc. DNA
Analyst Ratings
- Consensus
- Reduce — 0 Buy · 1 Hold · 1 Sell (2 analysts)
- Avg. Price Target
- $7.00 (-44.0% downside)
Key Stats
- Today's Range
- $12.11 – $13.16
- 50-Day Range
- $6.47 – $13.41
- 52-Week Range
- $5.37 – $17.58
- Volume
- 2.91 million shs
- Average Volume
- 1.75 million shs
- Market Cap
- $863.98 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 2.06
- Price / Sales
- 7.72
Short Interest
- Short Interest
- 18.73%
- Days to Cover
- 1.25
Financials (TTM)
- Revenue
- $111.86 million
- Net Income
- $-290,803,000
- Net Margin
- -259.96%
- Return on Equity
- -69.19%
- Debt-to-Equity
- —
About Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Related Stocks
Compare head-to-head: DNA vs AMGN·DNA vs MRNA·DNA vs TWST·DNA vs HALO
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.